Thailand To Stop Using Sinovac Covid Vaccine When Stocks End This Month
NDTV
Thailand used over 31.5 million Sinovac doses since February, starting with two doses to frontline workers, high-risk groups, and residents of Phuket.
Thailand will stop using the COVID-19 vaccine of China's Sinovac when its current stock finishes, a senior official said, having used the shot extensively in combination with Western-developed vaccines. Thailand used over 31.5 million Sinovac doses since February, starting with two doses to frontline workers, high-risk groups, and residents of Phuket, a holiday island that reopened to tourists early in a pilot scheme.
In July, Thailand started inoculating people with Sinovac as a first dose followed by the Oxford University-developed AstraZeneca
Thailand was the first country to combine Chinese and Western shots, a strategy its health officials said has proved effective
"We expect to have distributed all Sinovac doses this week," said health official Opas Karnkawinpong, adding the programme will switch to combining the AstraZeneca vaccine with that made by Pfizer and BioNTech
